Mela Sciences Prices Public Offering of Common Stock; Termination of at the Market (ATM) Equity Offering Program; and Execution of Term Sheet for Debt Financing

Published: Feb 12, 2013

IRVINGTON, N.Y., Feb. 12, 2013 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), the medical device company focused on the design, development and commercialization of MelaFind®, today announced the pricing of an underwritten offering of 6,100,000 shares of its common stock at an offering price of $1.30 per share.

Back to news